ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Opfolda 65 mg, Hartkapseln - 24
67806002 Amicus Therapeutics Switzerland GmbH
Opfolda 65 mg, Hartkapseln04.07.2024
  04.07.2024
Miglustat (A16AX06) 
WHO-DDD03.07.2029
07.14.24
07.99. 
B  
Yes 
IPCI
1005.78Yes
    
10 %1110.25
7680678060020Synthetika
  
Composition
Kapsel: miglustatum 65 mg, cellulosum microcristallinum, maydis amylum, sucralosum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: gelatina, E 171, E 172 (nigrum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDoseadditional_information
Miglustate65 mgKapsel
BAG: Active AgentDose
Miglustate65 mg
 
Inactive agents additional_information
(Nigrum)  
Ammoniae Solutio Concentrata  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Maydis Amylum  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Sucralosum  
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home